Global Cord Blood (NYSE:CO) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO) in a research report issued to clients and investors on Tuesday. The firm set a “strong-buy” rating on the medical research company’s stock.

Global Cord Blood Stock Down 43.5 %

NYSE CO opened at $0.65 on Tuesday. Global Cord Blood has a fifty-two week low of $2.03 and a fifty-two week high of $5.50. The business has a 50 day moving average price of $0.95 and a two-hundred day moving average price of $1.18. The stock has a market cap of $79.01 million, a PE ratio of 1.02 and a beta of 0.16.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.